AngioDynamics (ANGO) Reports In-Line Q4 EPS ; Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $90.74 million.

GUIDANCE:

AngioDynamics sees FY2024 EPS of $0.28-$0.34, versus the consensus of ($0.08). AngioDynamics sees FY2024 revenue of $328-333 million, versus the consensus of $323 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance